Abstract
The anticancer effects of human amniotic membrane (hAM) have been studied over the last decade. However, the action mechanisms responsible for these effects are not fully understood until now. Previously results reported by our team proved that hAM is able to induce cytotoxicity and cell death in hepatocellular carcinoma (HCC), a worldwide high incident and mortal cancer. Therefore, this experimental study aimed to investigate the cellular targets of hAM protein extracts (hAMPE) in HCC through in vitro studies. Our results showed that hAMPE is able to modify oxidative stress environment in all HCC cell lines, as well as its cell cycle. hAMPE differently targets deoxyribonucleic acid (DNA), P21, P53, β-catenin and multidrug resistance (MDR) proteins in HCC cell lines. In conclusion, hAMPE has several targets in HCC, being clear that the success of this treatment depends of a personalized therapy based on the biological and genetic characteristics of the tumor.
Original language | English |
---|---|
Pages (from-to) | 689-97 |
Number of pages | 9 |
Journal | Pathology oncology research : POR |
Volume | 22 |
Issue number | 4 |
DOIs | |
Publication status | Published - Oct 2016 |
Externally published | Yes |
Keywords
- ATP Binding Cassette Transporter, Subfamily B/metabolism
- Amnion/metabolism
- Antineoplastic Agents/pharmacology
- Apoptosis/drug effects
- Carcinoma, Hepatocellular/drug therapy
- Cell Cycle/drug effects
- Cell Cycle Proteins/metabolism
- Cell Line, Tumor
- Cyclin-Dependent Kinase Inhibitor p21/metabolism
- DNA/metabolism
- Hep G2 Cells
- Humans
- Liver Neoplasms/drug therapy
- Membrane Proteins/metabolism
- Oxidative Stress/drug effects
- Tumor Suppressor Protein p53/metabolism
- beta Catenin/metabolism